Over 2.2 million Americans suffer from glaucoma — now a new procedure may relieve symptoms. Glaucoma is a disease in which there is a buildup of pressure behind the eye. The pressure often damages the ...

Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating Leading Efficacy & Safety Across the Entire Glaucoma Disease Spectrum SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos ...

While Both iStent and iStent inject Showed Significant IOP and Medication Reduction in Combo-Cataract Procedures at 1 Year Postoperative, iStent inject Achieved Greater Absolute IOP Declines with 93% ...

Robert J. Cionni, MD - Cataract Surgeon in Salt Lake City Click here for high-resolution version SALT LAKE CITY, UT--(Marketwire - Nov 13, 2012) - Dr. Robert J. Cionni, MD of The Eye Institute of Utah ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Please provide your email address to receive an email when new articles are posted on . After 6 months, fewer medications were used in eyes treated with iStent inject. Keratograph bulbar redness and ...

Please provide your email address to receive an email when new articles are posted on . “Elevated [IOP] is one of the major risk factors for development and progression of POAG [primary open-angle ...

(RTTNews) - Glaukos Corp. (GKOS) has submitted a supplemental pre-market approval application to the FDA for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is an ...

The US Food and Drug Administration (FDA) has approved the iStent, the smallest medical implant ever, for use in combination with cataract surgery to treat glaucoma. The US Food and Drug ...

Here are five key notes: 1. The iStent inject is approved by the Australian Therapeutics Goods Administration for use in conjunction with cataract surgery for the resection of intraocular pressure in ...